Protein Hydrolysate/Leucine Co-Ingestion Reduces the Prevalence of Hyperglycemia in Type 2 Diabetic Patients

Protein hydrolysate/leucine coingestion could represent an effective nutritional intervention to stimulate postprandial insulin secretion, augment postprandial blood glucose disposal, and improve blood glucose homeostasis in type 2 diabetic patients (8-10).

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2006-12, Vol.29 (12), p.2721-2722
Hauptverfasser:	Manders, Ralph J.F, Praet, Stephan F.E, Meex, Ruth C.R, Koopman, René, Roos, André L. de, Wagenmakers, Anton J.M, Saris, Wim H.M, Loon, Luc J.C. van
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Amino acids Beverages Biological and medical sciences Blood Glucose - drug effects Blood Glucose - metabolism Blood sugar Cardiovascular disease Cardiovascular diseases Circadian Rhythm Complications and side effects Control Diabetes Diabetes Mellitus, Type 2 - blood Diabetes. Impaired glucose tolerance Diabetics Endocrine pancreas. Apud cells (diseases) Endocrinopathies Epidemiology Etiopathogenesis. Screening. Investigations. Target tissue resistance General aspects Health aspects Humans Hyperglycemia Hyperglycemia - epidemiology Hyperglycemia - prevention & control Leucine - administration & dosage Leucine - therapeutic use Living conditions Medical sciences Monitoring systems Prevalence Prevention Protein Hydrolysates - administration & dosage Protein Hydrolysates - therapeutic use Public health. Hygiene Public health. Hygiene-occupational medicine Reference Values Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Protein hydrolysate/leucine coingestion could represent an effective nutritional intervention to stimulate postprandial insulin secretion, augment postprandial blood glucose disposal, and improve blood glucose homeostasis in type 2 diabetic patients (8-10).
ISSN:	0149-5992 1935-5548
DOI:	10.2337/dc06-1424